David Hinton | AIChE

David Hinton

Professor, MD, FARVO
University of Southern California

David R. Hinton MD, FARVO is a board certified Pathologist (Neuropathology) with over 20 yrs. experience evaluating the pathogenesis of blinding retinal disorders with a focus on age related macular degeneration (AMD). He is the Gavin S. Herbert Professor of Retinal Research and Professor of Pathology and Ophthalmology at the Keck School of Medicine of the University of Southern California. He is widely known for his expertise in the basic biology of the retinal pigment epithelium (RPE), in the evaluation of retinal disease models in vitro and in vivo, and in the development of novel therapeutic approaches to retinal disease. A major area of effort relates to evaluating the neuroprotective role of RPE-derived alphaB crystallin and mitochondrial-derived peptides in the outer retina. As co-PI of the “California Project to Cure Blindness”, he leads a multi-institutional team developing a stem cell-derived cellular therapy for atrophic AMD.  He is funded by the National Eye Institute (NIH) and the California Institute for Regenerative Medicine (CIRM).